Compare HUBB & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUBB | WST |
|---|---|---|
| Founded | 1888 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5B | 20.2B |
| IPO Year | N/A | N/A |
| Metric | HUBB | WST |
|---|---|---|
| Price | $456.99 | $277.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $488.43 | $345.75 |
| AVG Volume (30 Days) | 471.0K | ★ 696.6K |
| Earning Date | 02-03-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.24% | 0.32% |
| EPS Growth | ★ 15.10 | 0.17 |
| EPS | ★ 15.99 | 6.75 |
| Revenue | ★ $5,686,200,000.00 | $3,017,900,000.00 |
| Revenue This Year | $5.89 | $7.01 |
| Revenue Next Year | $7.65 | $6.20 |
| P/E Ratio | ★ $28.54 | $40.98 |
| Revenue Growth | 0.82 | ★ 4.92 |
| 52 Week Low | $299.43 | $187.43 |
| 52 Week High | $484.26 | $348.90 |
| Indicator | HUBB | WST |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | 54.34 |
| Support Level | $424.69 | $264.92 |
| Resistance Level | $466.67 | $278.43 |
| Average True Range (ATR) | 11.16 | 6.74 |
| MACD | 1.78 | 0.66 |
| Stochastic Oscillator | 75.26 | 65.94 |
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.